BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mishra P, Laha D, Grant R, Nilubol N. Advances in Biomarker-Driven Targeted Therapies in Thyroid Cancer. Cancers (Basel) 2021;13:6194. [PMID: 34944814 DOI: 10.3390/cancers13246194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Li G, Chen W, Gong Y, Wei T, Gong R, Zhu J, Li Z, Lei J. Identification of Circulating Exosomal microRNAs Associated with Radioiodine Refractory in Papillary Thyroid Carcinoma. J Pers Med 2022;12. [PMID: 36556238 DOI: 10.3390/jpm12122017] [Reference Citation Analysis]
2 Macerola E, Poma AM, Vignali P, Proietti A, Ugolini C, Torregrossa L, Basolo A, Elisei R, Santini F, Basolo F. Predictive Biomarkers in Thyroid Cancer. Front Oncol 2022;12:901004. [DOI: 10.3389/fonc.2022.901004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang K, Qian R, Li H, Wang C, Ding Y, Gao Z. Interpreting the Pharmacological Mechanisms of Sho-saiko-to on Thyroid Carcinoma through Combining Network Pharmacology and Experimental Evaluation. ACS Omega 2022;7:11166-76. [PMID: 35415320 DOI: 10.1021/acsomega.1c07335] [Reference Citation Analysis]